Related references
Note: Only part of the references are listed.Quality of Methods for Assessing and Reporting Serious Adverse Events in Clinical Trials of Cancer Drugs
S. M. Belknap et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
The inter-rater agreement of retrospective assessments of adverse events does not improve with two reviewers per patient record
Marieke Zegers et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
The Missing Voice of Patients in Drug-Safety Reporting
Ethan Basch
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Ethan Basch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the national cancer institute-sponsored clinical trials networks
Deborah Watkins Bruner et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Patient-reported outcomes and the evolution of adverse event reporting in oncology
Andy Trotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Precision of health-related quality-of-life data compared with other clinical measures
Elizabeth A. Hahn et al.
MAYO CLINIC PROCEEDINGS (2007)
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study
Ethan Basch et al.
LANCET ONCOLOGY (2006)
Quality of life and pain in advanced stage prostate cancer: Results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone
Donna L. Berry et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Cancer symptom assessment instruments: A systematic review
J Kirkova et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Patient-reported medication symptoms in primary care.
SN Weingart et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Better reporting of harms in randomized trials: An extension of the CONSORT statement
JPA Ioannidis et al.
ANNALS OF INTERNAL MEDICINE (2004)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Adverse drug event monitoring at the Food and Drug Administration - Your report can make a difference
SR Ahmad
JOURNAL OF GENERAL INTERNAL MEDICINE (2003)
Share Paper
